Paper41236668
Zn containing mesoporous bioglasses with enhanced textural and antibacterial properties produced by three modifications of the sol-gel method.
Beketova A and 14 others. J Mater Sci Mater Med, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Zn containing mesoporous bioglasses with enhanced textural and antibacterial properties produced by three modifications of the sol-gel method. Papers, record 41236668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41236668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Zn containing mesoporous bioglasses with enhanced textural and antibacterial properties produced by three modifications of the sol-gel method.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Ceramics | Major topic |
| Zinc | Major topic |
| Porosity | |
| Humans | |
| Biocompatible Materials | |
| Materials Testing | |
| X-Ray Diffraction | |
| Fibroblasts | |
| Glass | |
| Hemolysis | |
| Periodontal Ligament | |
| Microbial Sensitivity Tests | |
| Gels |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GA 101106882 | RegrOssBio HORIZON-MSCA-2022-PF-01-01 | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35528069 | Synthesis and compatibility evaluation of versatile mesoporous silica nanoparticles with red blood cells: an overview. | RSC Adv | 2019 | https://conductscience.org/library/papers/35528069 | PubMed |
| 2 | 31349470 | Ag modified mesoporous bioactive glass nanoparticles for enhanced antibacterial activity in 3D infected skin model. | Mater Sci Eng C Mater Biol Appl | 2019 | https://conductscience.org/library/papers/31349470 | PubMed |
| 3 | 36804821 | Trends and perspectives on the commercialization of bioactive glasses. | Acta Biomater | 2023 | https://conductscience.org/library/papers/36804821 | PubMed |
| 4 | 36497685 | Antibiotic Resistance in Patients with Peri-Implantitis: A Systematic Scoping Review. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36497685 | PubMed |
| 5 | 25016134 | In vitro cytotoxicity of hydrothermally synthesized ZnO nanoparticles on human periodontal ligament fibroblast and mouse dermal fibroblast cells. | Toxicol In Vitro | 2014 | https://conductscience.org/library/papers/25016134 | PubMed |
| 6 | 34821257 | Porous bioactive glass micro- and nanospheres with controlled morphology: developments, properties and emerging biomedical applications. | Mater Horiz | 2021 | https://conductscience.org/library/papers/34821257 | PubMed |
| 7 | 28412552 | Copper-containing mesoporous bioactive glass nanoparticles as multifunctional agent for bone regeneration. | Acta Biomater | 2017 | https://conductscience.org/library/papers/28412552 | PubMed |
| 8 | 21762155 | Zinc in the mouth, its interactions with dental enamel and possible effects on caries; a review of the literature. | Int Dent J | 2011 | https://conductscience.org/library/papers/21762155 | PubMed |
| 9 | 15547911 | Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. | Angew Chem Int Ed Engl | 2004 | https://conductscience.org/library/papers/15547911 | PubMed |
| 10 | 33947544 | Cerium and gallium containing mesoporous bioactive glass nanoparticles for bone regeneration: Bioactivity, biocompatibility and antibacterial activity. | Mater Sci Eng C Mater Biol Appl | 2021 | https://conductscience.org/library/papers/33947544 | PubMed |
| 11 | 38607110 | Strontium and Zinc Co-Doped Mesoporous Bioactive Glass Nanoparticles for Potential Use in Bone Tissue Engineering Applications. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38607110 | PubMed |
| 12 | 20230032 | Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/20230032 | PubMed |
| 13 | 34742452 | Self-healing polysaccharide-based injectable hydrogels with antibacterial activity for wound healing. | Carbohydr Polym | 2022 | https://conductscience.org/library/papers/34742452 | PubMed |
| 14 | 18274517 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. | Nat Protoc | 2008 | https://conductscience.org/library/papers/18274517 | PubMed |
| 15 | 38929648 | The Impact of Peri-Implant Diseases on the General Status of Patients with Cardiovascular Diseases: A Literature Review. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38929648 | PubMed |
| 16 | 32717329 | Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection. | Acta Biomater | 2020 | https://conductscience.org/library/papers/32717329 | PubMed |
| 17 | 35642539 | Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? | Chem Soc Rev | 2022 | https://conductscience.org/library/papers/35642539 | PubMed |
| 18 | 28364954 | Sol-gel processing of bioactive glass nanoparticles: A review. | Adv Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/28364954 | PubMed |
| 19 | 31380344 | Toward Highly Dispersed Mesoporous Bioactive Glass Nanoparticles With High Cu Concentration Using Cu/Ascorbic Acid Complex as Precursor. | Front Chem | 2019 | https://conductscience.org/library/papers/31380344 | PubMed |
| 20 | 35021502 | Incorporation of ZnO/Bioactive Glass Nanoparticles into Alginate/Chitosan Composite Hydrogels for Wound Closure. | ACS Appl Bio Mater | 2019 | https://conductscience.org/library/papers/35021502 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41977548 | Development of Chitosan Nanocomposite Films Reinforced with Metal Oxides and Lignin Derivatives for Sustainable Food Packaging. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/41977548 | PubMed |
| 41441514 | Calcium-Enriched Magnetic Core-Shell Mesoporous Nanoparticles for Potential Application in Bone Regeneration. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/41441514 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41236668
GET https://conductscience.org/api/papers/v1/41236668/references?page=2